BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day
Go back to BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day| ATA, Inc. (NASDAQ: ATAI) | Delayed: 4.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.17 | 52 Week High | $7.32 | |||
| Open | $4.17 | 52 Week Low | $3.30 | |||
| Day High | $4.17 | P/E | N/A | |||
| Day Low | $4.17 | EPS | $0.00 | |||
| Volume | 16,504 | |||||
